Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma

计划入组 28 人 · 首次发布于 2006 年 3 月 27 日

Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents

计划入组 600 人 · 首次发布于 2021 年 8 月 20 日

Phase II Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell)

计划入组 450 人 · 首次发布于 2023 年 3 月 15 日

Baculovirus gastointestinal-cancer vaccine (Wistar)

Baculovirus gastointestinal-cancer vaccine(The Wistar Institute)

Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)

SFJ Pharmaceuticals, Inc.

United States

SFL Pharmaceuticals Deutschland GmbH

SFJ Pharmaceuticals X, LTD.

Lexeo Therapeutics to Showcase Advanced AAV Manufacturing Platform at ASGCT Annual Meeting

QIAGEN Expands QIAcuity Digital PCR Ecosystem with New Gene Expression Assays, High-Multiplex Capabilities, and Workflow Automation

Study Charts rAAV Dose Costs by Indication and Identifies Cost-Cutting Strategies